Cargando…

Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study

OBJECTIVES: Determine the effect of the catheter to vein ratio (CVR) on rates of symptomatic thrombosis in individuals with a peripherally inserted central catheter (PICC) and identify the optimal CVR cut-off point according to diagnostic group. DESIGN: Retrospective cohort study. SETTING: 4 tertiar...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharp, Rebecca, Carr, Peter, Childs, Jessie, Scullion, Andrew, Young, Mark, Flynn, Tanya, Kirker, Carolyn, Jackson, Gavin, Esterman, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258560/
https://www.ncbi.nlm.nih.gov/pubmed/34226216
http://dx.doi.org/10.1136/bmjopen-2020-045895
_version_ 1783718521106071552
author Sharp, Rebecca
Carr, Peter
Childs, Jessie
Scullion, Andrew
Young, Mark
Flynn, Tanya
Kirker, Carolyn
Jackson, Gavin
Esterman, Adrian
author_facet Sharp, Rebecca
Carr, Peter
Childs, Jessie
Scullion, Andrew
Young, Mark
Flynn, Tanya
Kirker, Carolyn
Jackson, Gavin
Esterman, Adrian
author_sort Sharp, Rebecca
collection PubMed
description OBJECTIVES: Determine the effect of the catheter to vein ratio (CVR) on rates of symptomatic thrombosis in individuals with a peripherally inserted central catheter (PICC) and identify the optimal CVR cut-off point according to diagnostic group. DESIGN: Retrospective cohort study. SETTING: 4 tertiary hospitals in Australia and New Zealand. PARTICIPANTS: Adults who had undergone PICC insertion. PRIMARY OUTCOME MEASURE: Symptomatic thrombus of the limb in which the PICC was inserted. RESULTS: 2438 PICC insertions were included with 39 cases of thrombosis (1.6%; 95% CI 1.14% to 2.19%). Receiver operator characteristic analysis was unable to be performed to determine the optimal CVR overall or according to diagnosis. The association between risk of thrombosis and CVR cut-offs commonly used in clinical practice were analysed. A 45% cut-off (≤45% versus ≥46%) was predictive of thrombosis, with those with a higher ratio having more than twice the risk (relative risk 2.30; 95% CI 1.202 to 4.383; p=0.01). This pattern continued when only those with malignancy were included in the analysis, those with cancer had twice the risk of thrombosis with a CVR greater than 45%. Whereas the 33% CVR cut-off was not associated with statistically significant results overall or in those with malignancy. Neither the 33% or 45% CVR cut-off produced statistically significant results in those with infection or other non-malignant conditions. CONCLUSIONS: Adherence to CVR cut-offs are an important component of PICC insertion clinical decision making to reduce the risk of thrombosis. These results suggest that in individuals with cancer, the use of a CVR ≤45% should be considered to minimise risk of thrombosis. Further research is needed to determine the risk of thrombosis according to malignancy type and the optimal CVR for those with a non-malignant diagnosis.
format Online
Article
Text
id pubmed-8258560
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-82585602021-07-23 Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study Sharp, Rebecca Carr, Peter Childs, Jessie Scullion, Andrew Young, Mark Flynn, Tanya Kirker, Carolyn Jackson, Gavin Esterman, Adrian BMJ Open Nursing OBJECTIVES: Determine the effect of the catheter to vein ratio (CVR) on rates of symptomatic thrombosis in individuals with a peripherally inserted central catheter (PICC) and identify the optimal CVR cut-off point according to diagnostic group. DESIGN: Retrospective cohort study. SETTING: 4 tertiary hospitals in Australia and New Zealand. PARTICIPANTS: Adults who had undergone PICC insertion. PRIMARY OUTCOME MEASURE: Symptomatic thrombus of the limb in which the PICC was inserted. RESULTS: 2438 PICC insertions were included with 39 cases of thrombosis (1.6%; 95% CI 1.14% to 2.19%). Receiver operator characteristic analysis was unable to be performed to determine the optimal CVR overall or according to diagnosis. The association between risk of thrombosis and CVR cut-offs commonly used in clinical practice were analysed. A 45% cut-off (≤45% versus ≥46%) was predictive of thrombosis, with those with a higher ratio having more than twice the risk (relative risk 2.30; 95% CI 1.202 to 4.383; p=0.01). This pattern continued when only those with malignancy were included in the analysis, those with cancer had twice the risk of thrombosis with a CVR greater than 45%. Whereas the 33% CVR cut-off was not associated with statistically significant results overall or in those with malignancy. Neither the 33% or 45% CVR cut-off produced statistically significant results in those with infection or other non-malignant conditions. CONCLUSIONS: Adherence to CVR cut-offs are an important component of PICC insertion clinical decision making to reduce the risk of thrombosis. These results suggest that in individuals with cancer, the use of a CVR ≤45% should be considered to minimise risk of thrombosis. Further research is needed to determine the risk of thrombosis according to malignancy type and the optimal CVR for those with a non-malignant diagnosis. BMJ Publishing Group 2021-07-05 /pmc/articles/PMC8258560/ /pubmed/34226216 http://dx.doi.org/10.1136/bmjopen-2020-045895 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Nursing
Sharp, Rebecca
Carr, Peter
Childs, Jessie
Scullion, Andrew
Young, Mark
Flynn, Tanya
Kirker, Carolyn
Jackson, Gavin
Esterman, Adrian
Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study
title Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study
title_full Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study
title_fullStr Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study
title_full_unstemmed Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study
title_short Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study
title_sort catheter to vein ratio and risk of peripherally inserted central catheter (picc)-associated thrombosis according to diagnostic group: a retrospective cohort study
topic Nursing
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258560/
https://www.ncbi.nlm.nih.gov/pubmed/34226216
http://dx.doi.org/10.1136/bmjopen-2020-045895
work_keys_str_mv AT sharprebecca cathetertoveinratioandriskofperipherallyinsertedcentralcatheterpiccassociatedthrombosisaccordingtodiagnosticgrouparetrospectivecohortstudy
AT carrpeter cathetertoveinratioandriskofperipherallyinsertedcentralcatheterpiccassociatedthrombosisaccordingtodiagnosticgrouparetrospectivecohortstudy
AT childsjessie cathetertoveinratioandriskofperipherallyinsertedcentralcatheterpiccassociatedthrombosisaccordingtodiagnosticgrouparetrospectivecohortstudy
AT scullionandrew cathetertoveinratioandriskofperipherallyinsertedcentralcatheterpiccassociatedthrombosisaccordingtodiagnosticgrouparetrospectivecohortstudy
AT youngmark cathetertoveinratioandriskofperipherallyinsertedcentralcatheterpiccassociatedthrombosisaccordingtodiagnosticgrouparetrospectivecohortstudy
AT flynntanya cathetertoveinratioandriskofperipherallyinsertedcentralcatheterpiccassociatedthrombosisaccordingtodiagnosticgrouparetrospectivecohortstudy
AT kirkercarolyn cathetertoveinratioandriskofperipherallyinsertedcentralcatheterpiccassociatedthrombosisaccordingtodiagnosticgrouparetrospectivecohortstudy
AT jacksongavin cathetertoveinratioandriskofperipherallyinsertedcentralcatheterpiccassociatedthrombosisaccordingtodiagnosticgrouparetrospectivecohortstudy
AT estermanadrian cathetertoveinratioandriskofperipherallyinsertedcentralcatheterpiccassociatedthrombosisaccordingtodiagnosticgrouparetrospectivecohortstudy